Healthcare / Medical Care FacilitiesLSE
$217.00
-4.00 (-1.81%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $131.1M · quality 67.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$869M
P/E
54.3x
↑EV/EBITDA
369.2x
↑ROE
2.2%
↑Gross Margin
45.3%
↓Debt/Equity
1.77
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+9.6%
FCF CAGR
+20.4%
FCF margin
10.4%
FCF / Net income
9.98x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.58B · net income $16.4M · FCF $163.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.58B | $1.58B | $1.51B | $1.36B | $1.20B |
| Net Income | $16.4M | $16.4M | $25.4M | $27.3M | $8.6M |
| EBITDA | $241.7M | $241.7M | $248.9M | $229.7M | $187.7M |
| EPS | 0.04 | 0.04 | 0.06 | 0.07 | 0.02 |
| Gross Margin | 45.3% | 45.3% | 45.2% | 45.9% | 44.9% |
| Operating Margin | 7.5% | 7.5% | 8.3% | 9.3% | 7.7% |
| Net Margin | 1.0% | 1.0% | 1.7% | 2.0% | 0.7% |
| Balance Sheet | |||||
| Debt/Equity | 1.77 | 1.77 | 1.71 | 1.70 | 1.63 |
| Current Ratio | 0.64 | 0.64 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $163.7M | $163.7M | $123.6M | $131.1M | $93.9M |
| Returns | |||||
| ROE | 2.2% | 2.2% | 3.4% | 3.7% | 1.2% |
| Valuation | |||||
| P/E | 54.25 | 54.25 | 3612.90 | 3401.52 | 11357.14 |
| EV/EBITDA | 369.19 | 369.19 | 375.21 | 409.05 | 529.51 |
| P/B | 118.41 | 118.41 | 123.13 | 125.36 | 134.44 |
| Growth & Yield | |||||
| Revenue Growth | 4.5% | 4.5% | 11.2% | 13.4% | — |
| EPS Growth | -35.5% | -35.5% | -6.1% | 214.3% | — |
| Dividend Yield | 0.7% | 0.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
683.7%
EPS terminal req.
$19.26
Spread vs growth
-719.2%
5Y implied EPS CAGR
257.3%
EPS terminal req.
$23.30
Spread vs growth
-292.8%
10Y implied EPS CAGR
98.3%
EPS terminal req.
$37.52
Spread vs growth
-133.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+8.4%
Start / end P/E
3250.0x → 5425.0x
EPS bridge
0.06 → 0.04
Residual
-23.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.